Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Severance Hospital, Seoul, Korea, Republic of
Atlantic Centre for Oral and Maxillofacial Surgery 1278 Tower Rd., Halifax, Nova Scotia, Canada
University Hospital, Newark, New Jersey, United States
BC Children's Hospital, Department of Anesthesia, Vancouver, British Columbia, Canada
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu, China
Children's Hospital Boston, Boston, Massachusetts, United States
University of Virginia Health System, Charlottesville, Virginia, United States
Ziv medical center liver unit, Safed, Israel, Israel
Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.